Dan Groman - Jun 15, 2022 Form 4 Insider Report for Enfusion, Inc. (ENFN)

Role
Chief Technology Officer
Signature
/s/ Blake Nielsen, as Attorney-in-Fact
Stock symbol
ENFN
Transactions as of
Jun 15, 2022
Transactions value $
$0
Form type
4
Date filed
6/17/2022, 09:43 PM
Previous filing
Oct 21, 2021
Next filing
Oct 27, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENFN Class A Common Stock Award $0 +6.34K +6.27% $0.00 107K Jun 15, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ENFN Stock Option (Right to Buy) Award $0 +10K $0.00 10K Jun 15, 2022 Class A Common Stock 10K $9.86 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consist of restricted stock units ("RSUs") awarded pursuant to the Enfusion, Inc. 2021 Stock Option and Incentive Plan (the "Plan"). The restricted stock units will vest in full as follows: 2,113, 2,113 and 2,113 restricted stock units will vest on June 15, 2023, June 15, 2024 and June 15, 2025, respectively.
F2 These options were granted under the Plan and shall become exercisable as follows: 3,334, 3,333 and 3,333 on June 15, 2023, June 15, 2024 and June 15, 2025, respectively.